Bacterial magnetic nanoparticles for biomedical
applications

19th February 2021by admin0

Magnetic nanoparticles biosynthesized by bacteria
might soon play an important role in biomedicine and biotechnology.
Researchers of the University of Bayreuth have now developed and
optimized a process for the isolation and purification of these
particles from bacterial cells. In initial tests, magnetosomes
showed good biocompatibility when incubated with human cell lines.
The results, presented in the journal Acta Biomaterialia, are
therefore a promising step toward the biomedical use of
magnetosomes in diagnostic imaging techniques or as carrier in
magnetic drug delivery applications.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright ©2024 New Fusion All Rights Reserved

      Designed by FallingBrick